Imaging of Abdominal Complications in Children With Acute Lymphoblastic Leukaemia

Abstract

Acute lymphoblastic leukaemia (ALL) is the most common paediatric malignancy and remains one of the most common causes of cancer-related death in children and adolescents. Five-year overall survival rates now exceed 90% with current multidrug chemotherapeutic regimens. This improvement, coupled with the toxicity of chemotherapy, has led to the mortality from treatment-related toxicity approaching rates that are associated with relapse. This manuscript reviews the imaging features of the common treatment-associated abdominal complications in children with ALL.